Filing Details
- Accession Number:
- 0001209191-11-058616
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-12-01 09:42:37
- Reporting Period:
- 2011-11-29
- Filing Date:
- 2011-12-01
- Accepted Time:
- 2011-12-01 09:42:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1002811 | Kensey Nash Corp | KNSY | Surgical & Medical Instruments & Apparatus (3841) | 363316412 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1049378 | Mccollister C Evarts | C/O 735 Pennsylvania Drive Exton PA 19341 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-11-29 | 5,000 | $21.00 | 32,163 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-11-29 | 5,000 | $24.33 | 27,163 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Nonemployee Directors Stock Options (right to buy) | Disposition | 2011-11-29 | 2,500 | $0.00 | 2,500 | $21.00 |
| Common Stock | Nonemployee Directors Stock Options (right to buy) | Disposition | 2011-11-29 | 2,500 | $0.00 | 2,500 | $21.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2001-12-05 | 2011-12-05 | No | 4 | M | Direct |
| 0 | 2004-12-05 | 2011-12-05 | No | 4 | M | Direct |
Footnotes
- The sales reported for Dr. Evarts in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in September 2011.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.20 to $24.52, inclusive. The reporting person undertakes to provide to Kensey Nash Corporation, any security holder of Kensey Nash Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth.
- Dr. Evarts was granted these stock options December 5, 2001 and has held them for almost ten years. As noted, they are due to expire on December 5, 2011.
Billionaire Hedge Funds
